CDXS 4.33 (+1.88%)
US1920051067BiotechnologyBiotechnology

Codexis (CDXS) Stock Highlights

4.33 | +1.88%
2024-11-21 05:00:32
Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products. The firms products and services include Screening and Evolution services, Enzymes, Screening Kits. It also develops protein engineering and biocatalyst platforms such as Codeevolver, Ketoreductases, Transminases, Imine reductases, etc. The company operates in two business segments namely Performance Enzymes and Novel Biotherapeutics. It generates maximum revenue from the Performance Enzymes segment. Geographically, it derives a majority of revenue from the APAC.

Statistics

Range Today
4.12 4.51
Volume Today 808.6K
Range 1 Year
1.85 4.91
Volume 1 Year 148.91M
Range 3 Year
1.45 39.89
Volume 3 Year 582.34M
Range 10 Year
1.45 42.01
Volume 10 Year 1.12B

Highlights

Market Capitalization 332.02M (small)
Floating Shares 62M
Current Price 4.33
Price To Earnings -4.85
Price To Revenue 4.4
Price To Book 4.52
Earnings Per Share -0.86
Payout Ratio 0%

Performance

Latest +1.88%
1 Month +27.35%
3 Months +43.85%
6 Months +19.28%
1 Year +113.3%
3 Years -88.18%
5 Years -70.86%
10 Years +83.47%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.